第六十九届世界卫生大会 临时议程项目 20.1
A69/INF./3 2016 年 5 月 13 日
2015 年各基金和捐助方的自愿捐款情况 1. 本报告是2014-2015年世卫组织规划和财务报告包括经审计的2015年财务报表1的内 容补充。附件中提供了下列附表： 附表1——各基金的自愿捐款情况 附表2——各基金和捐助方的自愿捐款情况 附表3——按基金和捐助方分列的递延收入情况 附表4——按期限和捐助方分列的应收自愿捐款（流动和非流动）情况 附表5——实物和服务自愿捐赠情况 附表6——2016年预收自愿捐款 2. 截至2015 年12月31日时的年度财务报告第 2.3 节和2.15 节概述了应收账款和收入的 会计政策1。尤其按照《国际公共部门会计准则》第 23号（“非交换交易收入”）确认 自愿捐款收入。自愿捐款收入在世卫组织和捐款方签署具有约束力的协议时予以记 录。如果协议列有条件，世卫组织则无法控制资源，仅在收到现金后才记录收入和应 收款额。如果捐款方未列明付款条件，或已列明在本会计年度付款，收入在当期予以 确认。如果在付款条件中列明于年末后付款，此款额记为递延收入。如果指明起始日 期为下一年度，则将收入认作下一财政年度，并将收到的现金记录为预付款。 3. 每项自愿捐款记在捐款分配项下。附件所附简表汇总了这些捐款分配项，按基金 和捐助方报告了收入情况。总额不足10 000美元的杂项收入和捐助方捐款并在一起，记 在“其它”项下。
1
文件 A69/45。
A69/INF./3
ANNEX
World Health Organization Schedule 1 – Voluntary contributions, by fund For the year ended 31 December 2015 (in US dollars) Notes General Fund Voluntary contributions – core Core voluntary contributions account Other voluntary contributions – core Voluntary assessed contributions Subtotal – voluntary contributions – core Voluntary contributions – specified Voluntary contributions – specified Contingency Fund for Emergencies UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction Stop TB Partnership UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases Subtotal – voluntary contributions – specified Total General Fund – Programme budget Fiduciary Fund Secretariat of the WHO Framework Convention on Tobacco Control Stop TB Partnership Global Drug Facility Roll Back Malaria Partnership Health Metrics Network Partnership for Maternal, Newborn and Child Health Standing Committee on Nutrition Alliance for Health Policy and Systems Research Global Health Workforce Alliance Stop TB Partnership European Observatory on Health Systems and Policies ESPEN fund Total Fiduciary Fund 6 4 5 3 333 717 205 700 5 987 471 2 365 055 (5 653 579) 6 975 988 761 035 5 443 541 53 664 004 4 1 846 951 (18 153 674) 7 774 877 12 248 822 (5 299 285) 21 853 752 (103 700) 13 059 127 1 226 101 11 417 912 3 243 131 (8 350 662) 4 368 806 4 2 3 1 666 853 528 14 296 219 27 763 420 34 008 028 1 809 528 713 1 102 622 648 8 834 937 272 060 111 729 645 131 949 106 116 286 259 15 662 847 2015 2014
12 662 16 314 732 1 725 240 561 1 836 970 206
(1 063 677) 27 291 077 1 869 764 141 2 001 713 247
(Increase)/decrease in allowance for doubtful receivables Elimination of Interfund transfers Total voluntary contributions 7
(650 968) (3 320 249) 1 838 442 530
25 610 (3 492 101) 2 051 910 760
2
Annex
A69/INF./3
Note 1. “Voluntary contributions – core” includes the following types of revenue: funds received to support the Programme budget as a whole, considered fully or highly flexible; and funds that are earmarked for purposes within the Programme budget, considered designated, or of a medium level of flexibility. Fully flexible funds and highly flexible funds, earmarked only at the level of the category, are recorded in the core voluntary contributions account. Designated funds, earmarked at the level of programme area, are not as tightly specified for detailed activity or expenditure line reporting as voluntary contributions – specified, yet are still earmarked rather than highly flexible so are categorized as voluntary contributions – core. In addition, voluntary assessed contributions are recognized as voluntary contributions – core. Note 2. “Voluntary contributions – specified” include Base programmes, Special programmes and collaborative arrangements and Outbreak and crisis response. Note 3. The Contingency Fund for Emergencies (CFE) was created in 2015 to provide temporary financing for emergency operations. For full details see note 6.3 to the Financial Statements for year ended 31 December 2015 within the WHO programmatic and financial report for 2014–2015, including audited financial statements for 2015 (document A69/45). Note 4. Effective 1 January 2015, the administration of the Stop TB Partnership and the Stop TB Partnership Global Drug Facility Fund has moved to the United Nations Office for Project Services (UNOPS). Negative revenue represents the cancellation of remaining amounts due under agreements and the transfer of funds to UNOPS under novated agreements. Note 5. Activities under the Health Metrics Network ceased in May 2013. Negative revenue represents refunds of unspent amounts. Note 6. The Expanded Special Project for Elimination of Neglected Tropical Diseases (EPSEN) Fund was created in 2015 following the closure of the African Programme for Onchocerciasis Control (APOC) operations. For full details see note 6.7 to the Financial Statements for year ended 31 December 2015 in document A69/45. Note 7. As reported in the Statement of Financial Performance for the year ended 31 December 2015 (see document A69/45), all activities implemented by WHO have been consolidated in the financial report. This includes voluntary contributions received under the General Fund and the Fiduciary Fund.Voluntary contributions reported in Schedules 1 and 2 of this report include incash contributions only. In-kind and in-service contributions are reported separately in the Statement of Financial Performance and detailed in Schedule 5 of this report.
3
4
A69/INF./3
World Health Organization Schedule 2 – Voluntary contributions, by fund and by contributor For the year ended 31 December 2015 (in US dollars) A. GENERAL FUND Special Programme of Research, Development and Research Training in Human Reproduction
Contributor Member States Angola Armenia Australia Austria Azerbaijan Bangladesh Belgium Bhutan Bolivia (Plurinational State of) Bosnia and Herzegovina Brazil Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Chad China Colombia
Core voluntary contributions account
Other voluntary contributions – core
Voluntary contributions – specified 120 204 50 000
Contingency Fund for Emergencies
Stop TB Partnership
Special Programme for Research and Training in Tropical Diseases
Total revenue (Note 1) 120 204 50 000 36 692 334 44 743 81 473 224 082
15 665 399
21 026 935 44 743 81 473 224 082
9 918 478 50 000 25 000 25 000 1 496 074 32 680 25 000 25 000 277 258 1 571 584 46 428 476 900 000 747 811 50 000 2 000 000 55 000 729 927
2 038 043
11 956 521 50 000 25 000 25 000 1 496 074 32 680 25 000 25 000 277 258 1 571 584 47 158 403 900 000
55 000
2 857 811 50 000
Annex
Annex
Contributor Côte d’Ivoire Cyprus Czech Republic Democratic People’s Republic of Korea Democratic Republic of the Congo Denmark Dominican Republic Ecuador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gambia Georgia Germany Ghana Greece Guatemala Guinea Guinea-Bissau Honduras India Indonesia Iraq
Core voluntary contributions account
Other voluntary contributions – core
Voluntary contributions – specified 25 000 133 690 45 194 25 000 451 687
Contingency Fund for Emergencies
Special Programme of Research, Development and Research Training in Human Reproduction
Stop TB Partnership
Special Programme for Research and Training in Tropical Diseases
Total revenue (Note 1) 25 000 133 690 45 194 25 000 451 687 5 120 328 25 000 25 000 1 750 767 137 299
5 120 328 25 000 25 000 1 750 767 137 299 367 783 30 000 25 000 5 958 830 1 907 968 3 275 080 7 413 503 500 000 50 000 5 538 015 1 942 171 50 000 12 000 000 125 000 25 000 4 774 267 761 987 25 000 1 000 000 1 096 491 816 993 75 000 32 967
400 750 30 000 25 000 9 233 910 9 321 471 500 000 50 000 7 451 499 75 000 1 942 171 50 000 12 000 000 125 000 25 000
A69/INF./3
5 774 267 761 987 25 000
5
6 Contributor Ireland Italy Japan Kuwait Kyrgyzstan Lao People’s Democratic Republic Lebanon Lesotho Liberia Lithuania Luxembourg Madagascar Malawi Malaysia Mauritania Mauritius Monaco Morocco Mozambique Namibia Nepal Netherlands New Zealand Nicaragua Nigeria Norway Pakistan 5 590 866 5 980 979 32 503 82 965 1 941 176 3 235 295 Core voluntary contributions account 1 092 896 200 535 Other voluntary contributions – core Voluntary contributions – specified 438 596 4 532 252 30 433 764 20 500 000 50 000 108 350 332 005 192 625 18 981 542 345 000 3 799 913 25 000 50 000 10 000 237 580 25 000 477 340 25 000 50 000 15 000 25 000 6 501 496 1 722 708 25 000 67 610 799 33 428 117 28 359 311 Contingency Fund for Emergencies
A69/INF./3
Special Programme of Research, Development and Research Training in Human Reproduction
Stop TB Partnership
Special Programme for Research and Training in Tropical Diseases
Total revenue (Note 1) 1 531 492 4 732 787
200 000
30 633 764 20 500 000 50 000 108 350 332 005 192 625 18 981 542 345 000
1 176 421
10 152 805 25 000 50 000
25 000
35 000 237 580 25 000 592 808 25 000 50 000 15 000 25 000
5 650 000
18 132 475 1 722 708 25 000 67 610 799
1 765 536
1 177 024
41 961 543 28 359 311
Annex
Annex
Contributor Paraguay Philippines Portugal Republic of Korea Republic of Moldova Romania Russian Federation Rwanda San Marino Saudi Arabia Senegal Sierra Leone Singapore Solomon Islands Somalia South Africa Spain Sri Lanka Sudan Swaziland Sweden Switzerland Tajikistan Thailand The former Yugoslav Republic of Macedonia Timor-Leste Tunisia
Core voluntary contributions account
Other voluntary contributions – core
Voluntary contributions – specified 40 000 30 000 446 416
Contingency Fund for Emergencies
Special Programme of Research, Development and Research Training in Human Reproduction
Stop TB Partnership
Special Programme for Research and Training in Tropical Diseases
Total revenue (Note 1) 40 000 30 000 446 416 11 695 118 50 000 25 462
3 740 878
7 954 240 50 000 25 462 8 364 625 25 000 165 929 14 263 748 25 000 5 543 410 100 000 405 201 25 000 86 400
8 451 025 25 000 165 929 14 263 748 25 000 5 543 410 100 000 405 201 25 000 272 060 1 995 615 25 000 125 000 15 000
272 060 1 644 738 350 877 25 000 125 000 15 000 23 930 384 3 586 957 716 332 943 528 14 479 354 50 000 1 292 237 84 513 99 500 25 000 19 968 46 339 4 786 077 1 421 572 5 221 175 (2 140 599)
35 597 496 17 347 284 50 000 1 358 544
A69/INF./3
84 513 99 500 25 000
7
8 Contributor Turkmenistan Uganda Ukraine United Arab Emirates United Kingdom of Great Britain and Northern Ireland United States of America Uzbekistan Viet Nam Yemen Zambia Zimbabwe Total Member States Abt Associates Inc. African Development Bank Group African Leaders Malaria Alliance (ALMA) African Programme for Onchocerciasis Control (APOC) Age UK Alere Inc. Alzheimer’s Association American Jewish World Service (AJWS) Americans for UNFPA Arab Gulf Programme for United Nations Development Organizations (AGFUND) Asia-Europe Foundation (ASEF) Association For Promoting Research In Nova Medical School (APIFCM) Association for Reproductive and Family Health (ARFH) 102 622 648 9 892 803 21 895 884 Core voluntary contributions account Other voluntary contributions – core Voluntary contributions – specified 827 355 25 000 365 266 13 160 000 156 864 701 304 890 489 25 000 252 311 25 000 75 000 168 864 862 657 187 114 274 19 105 011 175 000 131 226 112 444 39 071 199 993 250 515 767 690 253 000 3 045 000 66 298 55 184 14 296 219 9 436 834 Contingency Fund for Emergencies
A69/INF./3
Special Programme of Research, Development and Research Training in Human Reproduction
Stop TB Partnership
Special Programme for Research and Training in Tropical Diseases
Total revenue (Note 1) 827 355 25 000 365 266 13 160 000
3 664 122 247 175
3 816 794 607 175
195 678 335 305 744 839 25 000 252 311 25 000 75 000 168 864
17 695 850
13 114 365
1 020 279 072 114 274 19 105 011 175 000 131 226 112 444 39 071 199 993
113 414
363 929 767 690 253 000 3 045 000 66 298 55 184
Annex
Annex
Contributor Autism Speaks BASF Corporation Bayer AG Becton Dickinson and Company (BD) Beijing Tiantan Biological Products Co. Ltd. Bill & Melinda Gates Foundation Bloomberg Family Foundation Borrow Dental Milk Foundation Bristol-Myers Squibb Carter Center CDC Foundation Changchun Institute Of Biological Products Co., Ltd. Cnbg Chiba University Child Health Research Foundation (CHRF) Children’s Investment Fund Foundation (UK) Christiansen Sarl Christoffel-Blindenmission Clarke Mosquito Community And Family Services International (CFSI) Community Development Fund CSL Limited David and Lucile Packard Foundation Deb Worldwide Healthcare Inc. Denka Seiken Co. Ltd. Disease Control Technologies Eisai Co., Ltd. Eli Lilly and Company Foundation, UK
Core voluntary contributions account
Other voluntary contributions – core
Voluntary contributions – specified 200 000 133 746 600 148 131 914 83 975 181 820 644 8 424 000 57 000 580 000 6 500 000 2 554 271 149 518 300 000 35 246 296 000 54 092 463 529 10 000 40 161 67 088 979 704
Contingency Fund for Emergencies
Special Programme of Research, Development and Research Training in Human Reproduction
Stop TB Partnership
Special Programme for Research and Training in Tropical Diseases
Total revenue (Note 1) 200 000 133 746 600 148 131 914 83 975
1 484 778
1 967 103
185 272 525 8 424 000 57 000 580 000 6 500 000 2 554 271 149 518 300 000 35 246 296 000 54 092 463 529 10 000 40 161 67 088 979 704
400 000 10 514 448 507 90 000 150 000 711 525
400 000 10 514 448 507 90 000 150 000 711 525
A69/INF./3
9
10 Contributor European Commission European Respiratory Society (ERS) FIA Foundation for the Automobile and Society Flemish Government, Belgium Focus Diagnostics, Inc. Fondation d’Harcourt Food and Agriculture Organization (FAO) Ford Foundation Foundation for Innovative New Diagnostics (FIND) GAVI Alliance Generalitat de Catalunya, Spain Gharda Chemicals Limited GlaxoSmithKline (GSK) Global Alliance for Improved Nutrition (GAIN) Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) Gojo Industries Inc. Government of Guam Government Of Punjab, Pakistan Government of Western Australia Grand Challenges Canada Green Cross Corporation Guarany Industria e Commercio H.D. Hudson Manufacturing Company Harvestplus Healthnet TPO Hilfsaktion Noma e.V. Ikea Foundation 100 000 126 421 673 1 794 157 36 100 7 769 202 113 000 1 382 490 20 065 59 473 4 418 262 139 000 424 767 316 593 10 000 20 000 200 000 23 209 293 000 5 524 862 Core voluntary contributions account Other voluntary contributions – core Voluntary contributions – specified 45 637 006 275 000 221 239 591 666 59 812 182 684 400 000 Contingency Fund for Emergencies
A69/INF./3
Special Programme of Research, Development and Research Training in Human Reproduction
Stop TB Partnership
Special Programme for Research and Training in Tropical Diseases
Total revenue (Note 1) 45 637 006 275 000 221 239
982 962
1 574 628 59 812 182 684 400 000
88 000
88 000 100 000 126 421 673 1 794 157 36 100 7 769 202 113 000 1 382 490 20 065 59 473 4 418 262 139 000 424 767 316 593 10 000 20 000 200 000 23 209
Annex
293 000 5 524 862
Annex
Contributor Ingv Istituto Nazionale di Geofisica e Vulcanologia Innovation Norway Intelligent Insect Control International Agency for the Prevention of Blindness (IAPB) International Centre For Sport Security (ICSS) International Labour Organization (ILO) International Organization for Migration (IOM) International Telecommunication Union (ITU) International Union against Tuberculosis and Lung Disease (IUATLD) International Vaccine Institute (IVI) International Water Association (IWA) Japan Hospital Association (JHA) Johann Jacobs Foundation John D. and Catherine T. Macarthur Foundation Joint United Nations Programme on HIV/AIDS (UNAIDS) Kaketsuken Kanazawa University Karolinska Institutet King’s College London KNCV Tuberculosis Foundation Korean Foundation for International Healthcare (KFIH) – Dr Lee Jong-Wook Memorial Fund La Métropole Grand Lyon Labiofam Liechtenstein Life Ideas Textiles Company Ltd.
Core voluntary contributions account
Other voluntary contributions – core
Voluntary contributions – specified 17 995 244 230 10 000 30 000 50 000 252 613 147 658 800 000 5 370 052 353 325 62 415 300 000 84 462 150 000 17 936 172 659 568 150 000 127 730 108 537 1 145 649 1 764 236 260 526 161 674 25 253 111 625
Contingency Fund for Emergencies
Special Programme of Research, Development and Research Training in Human Reproduction
Stop TB Partnership
Special Programme for Research and Training in Tropical Diseases
Total revenue (Note 1) 17 995 244 230 10 000 30 000 50 000 252 613 147 658 800 000 5 370 052 353 325 62 415 300 000 84 462
125 000
275 000 17 936 172 659 568 150 000 127 730 108 537 1 145 649 1 764 236 260 526 161 674 25 253 111 625
A69/INF./3
11
12 Contributor Lifestraw SA Lions Clubs International Foundation Ludwig Maximilians Universität, München L’Union Économique et Monétaire Ouest-Africaine (UEMOA) Marius Nasta Institute for Pneumology Medicines for Malaria Venture (MMV) Medimmune Mental Health Commission Of Canada (MHCC) Merck Merck Sharp and Dohme-Chibret Micronutrient Initiative (MI) Nagasaki University Nantong Gongcheng Fine Chemicals National Hospital Organization Kurihama Medical and Addiction Center National Philanthropic Trust (NPT) New Venture Fund (NVF) Niigata University Nippon Foundation Novartis Oceania Countries OPEC Fund for International Development (OFID) Open Society Institute Options Consultancy Services Ltd. Organisation for Economic Co-operation and Development (OECD) Pan American Health Organization (PAHO) 149 571 357 080 36 100 152 250 86 252 168 400 000 593 250 2 300 000 6 992 742 25 000 1 256 494 10 800 916 896 10 000 94 000 Core voluntary contributions account Other voluntary contributions – core Voluntary contributions – specified 38 010 624 890 42 199 15 177 183 509 225 000 1 399 580 110 000 439 702 Contingency Fund for Emergencies
A69/INF./3
Special Programme of Research, Development and Research Training in Human Reproduction
Stop TB Partnership
Special Programme for Research and Training in Tropical Diseases
Total revenue (Note 1) 38 010 624 890 42 199 15 177 183 509 225 000 1 399 580 110 000
152 550 2 457 453
592 252 2 457 453 149 571 357 080 36 100 152 250 86 252 168 400 000 593 250 2 300 000 6 992 742 25 000 1 256 494 10 800 916 896 10 000 94 000
Annex
Annex
Contributor Pilipinas Shell Foundation, Inc. Population Services International (PSI) President & Fellows of Harvard College Procter & Gamble SA Program for Appropriate Technology In Health (PATH) Queensland University Of Technology Research Foundation for Microbial Diseases of Osaka University Richter Gedeon Vegyeszeti Gyar Rockefeller Foundation Romanian Angel Appeal Foundation Rotary International Rotary of Japan Royal Tropical Institute (KIT), Netherlands S. C. Johnson and Son, Inc. Sabin Vaccine Institute Saerfu (Henan) Agrochemical Co., Ltd. Safetynet (Southeast Asia Field Epidemiology Training and Technology Network) Saint Petersburg Scientific Research Institute of Vaccines and Sera Sanofi Pasteur Save The Children UK Secretariat of the Pacific Community (SPC) Servicio Madrileno de Salud (SERMAS) Shanghai Institute Of Biological Products Co., Ltd. Sharda Cropchem Limited Shinnyo-En
Core voluntary contributions account
Other voluntary contributions – core
Voluntary contributions – specified 252 943 1 191 380 219 557 50 000 432 456
Contingency Fund for Emergencies
Special Programme of Research, Development and Research Training in Human Reproduction
Stop TB Partnership
Special Programme for Research and Training in Tropical Diseases
Total revenue (Note 1) 252 943 1 191 380 219 557 50 000 432 456
78 419 448 507 840 380 300 000 109 401 56 302 924 30 000 24 194 10 000 897 609 36 100 141 000 22 477 6 158 152 562 628 55 000 187 246 139 959 18 000 115 000
78 419 448 507 840 380 300 000 109 401 56 302 924 30 000 24 194 10 000 897 609 36 100 141 000 22 477 6 158 152 562 628 55 000 187 246
A69/INF./3
139 959 18 000 115 000
13
14 Contributor Shobikaa Impex Private Limited Sightsavers International Sinovac Biotech Ltd. Southeast Asia Tobacco Control Alliance (SEATCA) St. Michael’s Hospital (SMH), Canada Stichting Katholieke Universiteit Sumitomo Chemical Co. Ltd. Syngenta Crop Protection AG Tagros Chemicals India Ltd. Tana Netting Co., Ltd. Task Force for Global Health (TFGH) The Brighton Collaboration Foundation The Fountain House Inc. The Government of Macao, SAR, People’s Republic of China The Government of Hong Kong, SAR, People’s Republic of China The Northern Territory Government Of Australia The Norwegian Institute of Public Health (NIPH) The Paul G. Allen Family Foundation The Sackler Institute For Nutrition Science UCB SA Union for International Cancer Control (UICC) UNITAID – International Drug Purchase Facility United Nations Central Emergency Response Fund (CERF) United Nations Children’s Fund (UNICEF) United Nations Development Programme (UNDP) 13 991 12 771 182 881 160 000 107 900 206 428 4 247 745 25 000 282 500 400 000 100 000 365 580 63 041 727 628 170 000 1 042 736 30 000 14 923 517 42 219 954 6 337 126 46 746 622 Core voluntary contributions account Other voluntary contributions – core Voluntary contributions – specified 61 618 453 867 139 959 78 535 Contingency Fund for Emergencies
A69/INF./3
Special Programme of Research, Development and Research Training in Human Reproduction
Stop TB Partnership
Special Programme for Research and Training in Tropical Diseases
Total revenue (Note 1) 61 618 453 867 139 959 78 535
75 000
75 000 12 771 182 881 160 000 107 900 206 428 4 247 745 25 000 282 500 400 000 113 991 365 580 63 041
628 902
1 356 530 170 000 1 042 736 30 000 14 923 517 42 219 954 6 337 126 474 902 47 221 524
Annex
Annex
Contributor United Nations Economic Commission for Europe (UNECE) United Nations Environment Programme (UNEP) United Nations Fund for International Partnerships (UNFIP) United Nations High Commissioner for Refugees (UNHCR) United Nations Human Settlements Programme (UN-Habitat) United Nations Industrial Development Organization (UNIDO) United Nations Institute for Training and Research (UNITAR) United Nations Office for Project Services (UNOPS) United Nations Office for the Coordination of Humanitarian Affairs (UNOCHA) United Nations Office on Drugs and Crime (UNODC) United Nations Population Fund (UNFPA) United States Fund for UNICEF Universidad Politecnica de Madrid University of Antwerp University Of Bergen University of Natural Resources and Life Sciences, Vienna University Research Co., LLC Uppsala Monitoring Centre Valent Biosciences Corporation Vector Control Innovations Private limited Vestergaard Frandsen A/S Wateraid America, Inc. (WAA)
Core voluntary contributions account
Other voluntary contributions – core
Voluntary contributions – specified 139 100 957 358 19 276 440 2 894 834 35 500 20 000 20 000 9 979 445 5 509 649 339 810 30 723 860 199 796
Contingency Fund for Emergencies
Special Programme of Research, Development and Research Training in Human Reproduction
Stop TB Partnership
Special Programme for Research and Training in Tropical Diseases
Total revenue (Note 1) 139 100 957 358
705 687
19 982 127 2 894 834 35 500 20 000 20 000 9 979 445 5 509 649 339 810 30 723 860 199 796
82 005 130 000 220 380 164 153 524 167 350 000 60 682 240 427 172 951 109 095
82 005 130 000 220 380 164 153 524 167 350 000 60 682 240 427 172 951 109 095
A69/INF./3
15
16 Contributor Wellcome Trust World Bank World Federation of Neurology World Food Programme (WFP) World Meteorological Organization (WMO) World Vision Australia (WVA) World Vision International Zeshan Foundation Interfund revenue (Note 2): Alliance for Health Policy and Systems Research (HSR) Roll Back Malaria Partnership (RBM) Other and miscellaneous receipts (note 3) Pass through funding Refunds to donors (note 4) Total General Fund 102 622 648 56 083 (650 000) (205 880) 9 106 997 194 355 66 000 4 456 686 (17 411 194) (10 852 410) 1 666 853 528 14 296 219 Core voluntary contributions account Other voluntary contributions – core Voluntary contributions – specified 7 314 109 1 100 000 50 000 151 099 886 484 74 129 651 843 94 160 Contingency Fund for Emergencies
A69/INF./3
Special Programme of Research, Development and Research Training in Human Reproduction 94 496 1 200 000
Stop TB Partnership
Special Programme for Research and Training in Tropical Diseases 1 250 000
Total revenue (Note 1) 7 408 605 3 550 000 50 000 151 099 886 484 74 129 651 843 94 160
165 000
359 355 66 000
393 524
(6 433) 19 095
(515 832)
4 384 028 (18 061 194) (11 039 195)
27 763 420
12 662
16 314 732
1 836 970 206
Note 1. Revenue from voluntary contributions is recognized in accordance with IPSAS 23 (Revenue from Non-Exchange Transactions). Revenue is recorded when a binding agreement is signed by WHO and the contributor. Where there are “subject to” clauses in an agreement, WHO does not control the resource and does not record the revenue and amount receivable until the cash is received. Where there are no payment terms specified by the contributor or payment terms are in the current accounting year, revenue is recognized in the current period. Where payment terms specify payment after the year end, the amount is reported as deferred revenue. Revenue recognition will be revised based on changes to the payment terms listed in the signed agreement. Where the start date is indicated as being in the following year, revenue is recognized in the following financial year with any cash receipt recorded as an advance – see Schedule 6. Note 2. Interfund revenue represents the transfer of funding internally between the General Fund and the Fiduciary Fund. These are recorded as an expense to the “donor” fund and as revenue to the “recipient” fund and are eliminated on consolidation. Note 3. Negative amounts represent a decrease in the revenue recognized in a prior period due to changes in contractual terms or a reduction in amounts receivable.
Annex
Note 4. Refunds to donors represent an outflow of resources based on a donor request following the submission of a final report showing a balance of unutilized funds. Refunds represent a decrease in the revenue recognized.
Annex
World Health Organization Schedule 2 – Voluntary contributions, by fund and by contributor For the year ended 31 December 2015 (in US dollars) B. FIDUCIARY FUNDS Secretariat of the WHO Framework Convention on Tobacco Control Partnership for Maternal, Newborn and Child Health Alliance for Health Policy and Systems Research European Observatory on Health Systems and Policies
Contributor Member States Australia Austria Belgium Brazil Canada Finland India Ireland Japan Kuwait Netherlands Norway Slovenia Sweden Switzerland United Kingdom of Great Britain and Northern Ireland United States of America Total Member States
Stop TB Partnership Global Drug Facility
Roll Back Malaria Partnership
Standing Committee on Nutrition
Global Health Workforce Alliance
Stop TB Partnership
ESPEN Fund
Total revenue (Note 1)
656 115 280 584 251 971 80 000 497 512 207 059 520 000 548 246 100 000 500 000 800 000 235 405 1 528 391 470 810 588 512 225 000 621 325 382 614 2 755 620 565 971 41 517 105 519 3 494 350 971 520 4 099 869 3 728 517 2 343 750 197 175 5 767 355 1 586 758 2 717 835 761 035 297 651 761 035 226 757 350 000
656 115 280 584 251 971 430 000 497 512 207 059 520 000 775 003 100 000 500 000 800 000 3 048 118 621 325 3 704 205 41 517 3 507 955 3 691 525 19 632 889
Bill & Melinda Gates Foundation Eli Lilly and Company Foundation, Switzerland European Commission European Health Management Association (EHMA) Food and Agriculture Organization (FAO) International Development Research Centre (IDRC) 671 835
3 075 008
200 594 226 000 778 297 561 167 34 237 130 000 19 522
3 275 602 226 000
A69/INF./3
2 011 299 34 237 130 000 19 522
17
18 Contributor International Forum Gastein (IFG) International Fund for Agricultural Development (IFAD) John D. and Catherine T. Macarthur Foundation Maastricht University Oxford Policy Management Region of Veneto, Italy Swiss Tropical and Public Health Institute Technische Universitaet Berlin The Health Foundation Union Nationale des Caisses d’Assurance Maladie (UNCAM), France United Nations Department of Economic and Social Affairs (UNDESA) World Bank Inter-fund revenue (note 2): WHO Regional Office For Europe (RGO) Other and miscellaneous receipts (note 3) Refunds to donors (note 4) Total Fiduciary Fund
A69/INF./3
Secretariat of the WHO Framework Convention on Tobacco Control
Stop TB Partnership Global Drug Facility
Roll Back Malaria Partnership
Partnership for Maternal, Newborn and Child Health
Standing Committee on Nutrition
Alliance for Health Policy and Systems Research
Global Health Workforce Alliance
Stop TB Partnership
European Observatory on Health Systems and Policies 12 553
ESPEN Fund
Total revenue (Note 1) 12 553 30 000 125 000
30 000 125 000 21 193 24 000 233 909 50 000 10 582 99 899 325 027 45 700
21 193 24 000 233 909 50 000 10 582 99 899 325 027 45 700
550 000
550 000
2 916 764
2 916 764
203 596
(1 125 923) (17 027 751)
(519 800)
(31 076) (5 848 503)
18 822
(1 454 381) (22 876 254)
1 846 951
(18 153 674)
7 774 877
3 333 717
205 700
5 987 471
2 365 055
(5 653 579)
6 975 988
761 035
5 443 541
Note 1. Revenue from voluntary contributions is recognized in accordance with IPSAS 23 (Revenue from Non-Exchange Transactions). Revenue is recorded when a binding agreement is signed by WHO and the contributor. Where there are “subject to” clauses in an agreement, WHO does not control the resource and does not record the revenue and amount receivable until the cash is received. Where there are no payment terms specified by the contributor or payment terms are in the current accounting year, revenue is recognized in the current period. Where payment terms specify payment after the year end, the amount is reported as deferred revenue. Revenue recognition will be revised based on changes to the payment terms listed in the signed agreement. Where the start date is indicated as being in the following year, revenue is recognized in the following financial year with any cash receipt recorded as an advance – see Schedule 6. Note 2. Inter-fund revenue represents the transfer of funding internally between the General Fund and the Fiduciary Fund. These are recorded as an expense to the “donor” fund and as revenue to the “recipient” fund and are eliminated on consolidation. Note 3. Negative amounts represent a decrease in the revenue recognized in a prior period due to changes in contractual terms or a reduction in amounts receivable. Note 4. Refunds to donors represent an outflow of resources based on a donor request following the submission of a final report showing a balance of unutilized funds. Refunds represent a decrease in the revenue recognized.
Annex
Annex
World Health Organization Schedule 3 – Deferred revenue, by fund and by contributor As at 31 December 2015 (in US dollars) GENERAL FUND Special Programme of Research, Development and Special Programme Research Training for Research and in Human Training in Tropical Reproduction Diseases
Contributor Member States Australia Cambodia Canada China Equatorial Guinea Germany Guinea Guinea-Bissau Italy Lao People’s Democratic Republic Monaco Netherlands New Zealand Norway Republic of Korea Russian Federation Saudi Arabia Solomon Islands Switzerland The former Yugoslav Republic of Macedonia Timor-Leste Turkmenistan Ukraine
Core voluntary contributions account
Voluntary contributions – specified 1 768 498 288 660 21 055 749 6 000 000 450 556 355 150 6 687 303 26 207 17 007 72 188 226 757
Total deferred revenue (Note 1) 1 768 498 288 660 21 055 749 6 000 000 450 556 355 150 6 687 303 26 207 17 007 72 188 226 757 35 145 108 2 120 441 275 255 6 005 557 13 134 765 4 754 822 50 000 8 169 022 58 606
11 961 956
23 183 152 2 120 441 275 255 6 005 557 13 134 765 4 754 822 50 000 8 169 022 58 606 94 500 1 654 710 251 036
A69/INF./3
94 500 1 654 710 251 036
19
20 Contributor United Kingdom of Great Britain and Northern Ireland United States of America Zimbabwe Total Member States American Jewish World Service (AJWS) Arab Gulf Programme for United Nations Development Organizations (AGFUND) Asia–Europe Foundation (ASEF) Bill & Melinda Gates Foundation Bloomberg Family Foundation Borrow Dental Milk Foundation CDC Foundation Eli Lilly and Company Foundation, UK European Commission Fondation d’Harcourt Ford Foundation GAVI Alliance Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) Government of Western Australia Grand Challenges Canada Helmholtz-Zentrum Geesthacht Zentrum für Material-und Kustenforschung GmbH (HZG) Hilfsaktion Noma e.V. International Union against Tuberculosis and Lung Disease (IUATLD) John D. and Catherine T. Macarthur Foundation Kanazawa University King’s College London La Métropole Grand Lyon Lions Clubs International Foundation Marius Nasta Institute for Pneumology Mental Health Commission Of Canada (MHCC) 160 000 298 647 65 132 624 890 45 978 55 000 2 178 697 450 000 200 000 313 525 31 346 586 000 5 529 948 11 961 956 Core voluntary contributions account Voluntary contributions – specified 72 162 776 327 265 400 887 169 590 869 67 800 155 000 1 455 000 238 479 291 485 000 30 000 815 287 865 425 21 908 447 365 366
A69/INF./3
Special Programme of Research, Development and Special Programme Research Training for Research and in Human Training in Tropical Reproduction Diseases 7 328 244 960 779 8 289 023 11 586 6 106 870 6 106 870
Total deferred revenue (Note 1) 85 597 890 1 288 044 400 887 195 948 718 79 386 155 000 1 455 000
5 258 648
3 764 918
247 502 857 485 000 30 000 815 287 865 425 21 908 447 365 366
12 000
12 000 2 178 697 450 000 200 000 313 525 31 346 586 000 5 529 948
100 000
100 000 160 000 298 647 65 132 624 890
Annex
45 978 55 000
Annex
Contributor OPEC Fund for International Development (OFID) Pilipinas Shell Foundation, Inc. Population Services International (PSI) Potsdam Institute for Climate Impact Research (PIK) Program for Appropriate Technology In Health (PATH) Rand Corporation Romanian Angel Appeal Foundation Save The Children UK Servicio Madrileno de Salud (SERMAS) Sharda Cropchem Limited Southeast Asia Tobacco Control Alliance (SEATCA) Stichting Katholieke Universiteit Syngenta Crop Protection AG The Brighton Collaboration Foundation The Government of Macao, SAR, People’s Republic of China The Norwegian Institute of Public Health (NIPH) UCB SA United Nations Children’s Fund (UNICEF) United Nations Development Programme (UNDP) United Nations Economic Commission for Europe (UNECE) United Nations Office for Project Services (UNOPS) United Nations Trust Fund for Human Security (UNTFHS) University Of Bergen University of Natural Resources and Life Sciences, Vienna Wellcome Trust Zeshan Foundation Other Total General Fund
Core voluntary contributions account
Voluntary contributions – specified 1 100 000 408 036 674 839 134 870 227 800 144 841 27 843 398 821 374 494 18 100 229 390 29 944 150 000 26 000 1 650 385 706 840 961 387 501 500 801 165 130 000 1 670 656 336 357 699 171 328 305 23 000 98 318 968 367
Special Programme of Research, Development and Special Programme Research Training for Research and in Human Training in Tropical Reproduction Diseases
Total deferred revenue (Note 1) 1 100 000 408 036 674 839 134 870 227 800 144 841 27 843 398 821 374 494 18 100 229 390 29 944 150 000 26 000 1 650 385 706 840 961 387 501 500 801 165 130 000 1 670 656 336 357 699 171 328 305 23 000 98 318
114 801 13 671 257 9 986 589
1 083 168 493 196 879
11 961 956
457 577 077
A69/INF./3
21
22
A69/INF./3
FIDUCIARY FUND Alliance for Health Policy and Systems Research European Observatory on Health Systems and Policy 32 823 1 406 250 308 497 1 030 365 9 847 2 000 000 1 714 747 1 030 365 42 670
Contributor Kuwait Sweden United Kingdom of Great Britain and Northern Ireland Bill & Melinda Gates Foundation European Commission Other Total Fiduciary Fund
Roll Back Malaria Partnership 2 000 000
Global Health Workforce Alliance
Total deferred revenue (Note 1) 2 000 000 32 823 1 406 250 308 497 1 030 365 9 847 4 787 782 38 904 220 536 888 881
REIMBURSABLE PROCUREMENT – funds received in advance of delivery of goods or services (Note 2) GRAND TOTAL
Note 1. Deferred revenue is recognized based on legally binding agreements between WHO and its contributors where funds are earmarked and due in a future period. Deferred revenue – current (US $339m) and non-current (US $197m) are reported separately in the Statement of Financial Position and detailed as part of Note 4.14 to the Financial Statements for the year ended 31 December 2015 in document A69/45. Note 2. As reimbursable procurement is an exchange transaction, any funds received in advance of delivery and services are reported as deferred revenue.
Annex
Annex
A69/INF./3
World Health Organization Schedule 4 – Voluntary contributions receivable – non-current and current (by age and by contributor) As at 31 December 2015 (in US dollars) Current Amounts Current receivables – Receivable – receivables – ageing more Current non-current ageing from than 360 receivables – (Note 1) 0 to 360 days days total (Note 1)
Contributor Member States Angola Australia Belgium Cambodia Canada China Cyprus Equatorial Guinea Germany Greece Guinea Guinea-Bissau India Italy Kazakhstan Kuwait Lao People’s Democratic Republic Liberia Luxembourg Monaco Netherlands New Zealand Nigeria Norway Republic of Korea Russian Federation Saudi Arabia Sierra Leone Solomon Islands Sweden Switzerland The former Yugoslav Republic of Macedonia Timor-Leste Turkmenistan Ukraine
120 204 912 697 1 590 979 18 785 226 513 4 009 050 3 000 000 62 250 17 046 699 3 000 000 133 690 450 556 14 071 628 908 2 373 903 6 687 303 26 207 1 000 000 68 027 25 844 1 500 000 500 000 72 188 6 796 772 69 778 113 379 17 572 554 848 176 226 757 18 843 932 1 272 265 340 500 373 228 3 059 379 8 756 510 3 091 427 4 378 255 13 471 496 1 942 875 75 000 32 823 4 587 828 5 117 419 58 606 63 000 827 355 74 500 827 355 566 302 67 416 1 802 225
120 204 1 590 979 18 785 62 250 17 046 699 3 000 000 133 690 2 252 782 628 908 2 373 903 6 687 303 26 207 1 000 000 68 027 25 844 500 000 72 188 6 796 772 69 778 226 757 18 843 932 1 272 265 340 500 373 228 3 091 427 4 378 255 13 471 496 1 942 875 75 000 32 823 5 184 835 58 606 74 500 827 355 566 302
23
A69/INF./3
Annex
Contributor United Arab Emirates United Kingdom of Great Britain and Northern Ireland United States of America Zimbabwe Total Member States
Current Amounts Current receivables – Current Receivable – receivables – ageing more non-current ageing from than 360 receivables – (Note 1) 0 to 360 days days total (Note 1) 96 000 40 158 609 81 267 400 887 86 131 274 58 493 603 234 390 933 10 042 384 014 909 127 929 098 1 520 154 124 198 804 96 000 60 013 756 358 589 736 10 042 511 944 007
American Jewish World Service (AJWS) Arab Gulf Programme for United Nations Development Organizations (AGFUND) Asia–Europe Foundation (ASEF) Azienda Ospedaliera di Padova Bill & Melinda Gates Foundation Bloomberg Family Foundation Borrow Dental Milk Foundation Carter Center CDC Foundation Child Health Research Foundation (CHRF) Children’s Investment Fund Foundation (UK) Deb Worldwide Healthcare Inc. Drugs for Neglected Diseases Initiative (Dndi) Eli Lilly and Company Foundation, UK European Commission European Respiratory Society (ERS) Fondation d’Harcourt Ford Foundation GAVI Alliance Generalitat de Catalunya, Spain Global Alliance for TB Drug Development Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) Government of Western Australia Grand Challenges Canada Helmholtz-Zentrum Geesthacht Zentrum für Material-und Kustenforschung GmbH (HZG) Hilfsaktion Noma e.V. International Union against Tuberculosis and Lung Disease (IUATLD) John D. and Catherine T. Macarthur Foundation Johns Hopkins University Kanazawa University Karolinska Institutet King’s College London
67 800 45 000 1 455 000
11 586 270 000 84 000
11 586 354 000
184 831 99 538 013 153 995 584 485 000 43 500 3 250 000 1 254 615 35 246 296 000 10 514 15 142 248 726 4 497 370 1 328 224 41 931 867 175 000 182 683 182 683 12 000 179 118 19 383 083 1 794 157 80 000 700 000 200 000 313 525 31 346 586 000 5 529 948 100 000 287 020 160 000 127 730 298 647 108 537 6 694 881 11 993 268 100 000
184 831 153 995 584 485 000 43 500 3 250 000 1 254 615 35 246 296 000 10 514 15 142 1 328 224 53 925 135 275 000 182 683 12 000 19 383 083 1 794 157 80 000 7 394 881 200 000 313 525 31 346 586 000 5 529 948 100 000 287 020 160 000 127 730 108 537
24
Annex
A69/INF./3
Contributor La Métropole Grand Lyon Lions Clubs International Foundation Maastricht University Marius Nasta Institute for Pneumology Mental Health Commission Of Canada (MHCC) Merck Nagasaki University Obafemi Awolowo University – Teaching Hospital Complex Oil Search Health Foundation OPEC Fund for International Development (OFID) Options Consultancy Services Ltd Pilipinas Shell Foundation, Inc. Population Services International (PSI) Potsdam Institute for Climate Impact Research (PIK) President & Fellows of Harvard College Program for Appropriate Technology In Health (PATH) Queen Elizabeth Diamond Jubilee Trust Rand Corporation Region of Emilia Romagna, Italy Region of Veneto, Italy Research in Advanced Medical Information and Telematics vzw (RAMIT) Rockefeller Foundation Romanian Angel Appeal Foundation Rotary International Royal Tropical Institute (KIT), Netherlands Save The Children UK Sclavo Vaccines Association Servicio Madrileno de Salud (SERMAS) Sharda Cropchem Limited Southeast Asia Tobacco Control Alliance (SEATCA) St. Michael’s Hospital (SMH) Stichting Katholieke Universiteit Syngenta Crop Protection AG Task Force for Global Health (TFGH) The Brighton Collaboration Foundation The Government of Macao, SAR, People’s Republic of China The Health Foundation The Norwegian Institute of Public Health (NIPH) The Sackler Institute For Nutrition Science UCB SA
Current Amounts Current receivables – Current Receivable – receivables – ageing more non-current ageing from than 360 receivables – (Note 1) 0 to 360 days days total (Note 1) 65 132 624 890 21 193 45 978 55 000 152 550 107 080 90 897 102 248 550 000 149 750 906 494 209 034 204 943 345 649 134 870 219 557 247 800 82 605 82 645 144 841 11 658 205 850 18 001 82 500 27 843 190 935 24 194 69 199 540 933 409 344 187 247 354 881 18 100 151 985 77 405 75 000 42 715 150 000 3 624 239 26 000 1 150 385 500 000 32 823 529 425 177 414 75 000 961 387 500 000 32 823 177 414 75 000 961 387 125 025 190 935 149 218 540 933 409 344 354 881 18 100 77 405 75 000 42 715 150 000 3 624 239 219 557 330 405 82 645 144 841 11 658 205 850 18 001 82 500 203 093 1 441 831 231 487 65 132 856 377 21 193 45 978 55 000 152 550 107 080 90 897 149 750 906 494 209 034 203 093 1 441 831
25
A69/INF./3
Annex
Contributor Union Nationale des Caisses d’Assurance Maladie (UNCAM), France United Nations Children’s Fund (UNICEF) United Nations Development Programme (UNDP) United Nations Economic Commission for Europe (UNECE) United Nations Entity for Gender Equality and the Empowerment of Women (UN Women) United Nations Environment Programme (UNEP) United Nations Office for Project Services (UNOPS) United Nations Population Fund (UNFPA) United Nations Trust Fund for Human Security (UNTFHS) Universitaetsklinikum Aachen, Germany Universitaetsklinikum Heidelberg, Germany University Of Bergen University of Cape Town University of Dundee University of Hohenheim University of Natural Resources and Life Sciences, Vienna University of Washington University Research Co., LLC Wellcome Trust World Meteorological Organization (WMO) Zeshan Foundation Other Revaluation of amounts due in foreign currencies FCTC voluntary assessed contributions Total amounts receivable
Current Amounts Current receivables – Current Receivable – receivables – ageing more non-current ageing from than 360 receivables – (Note 1) 0 to 360 days days total (Note 1) 325 027 668 667 417 064 130 000 22 190 277 243 1 892 285 248 000 336 357 159 300 278 774 472 452 226 719 136 859 111 902 58 800 328 305 105 917 41 107 411 147 4 152 866 886 484 98 318 339 668 14 897 816 096 176 828 99 490 324 112 22 190 601 355 1 892 285 347 490 336 357 159 300 278 774 226 719 136 859 111 902 58 800 105 917 41 107 411 147 4 968 962 1 063 312 98 318 354 565 (26 771 334) 3 596 197 471 247 640 576 569 1 799 444 152 522 838 1 803 040 766 328 073 1 713 818 731 201 163 741 325 027 1 399 868 1 877 559
Note 1. Voluntary contributions receivable – current and non-current are reported in the Statement of Financial Position and detailed as part of Note 4.3 to the Financial Statements for the year ended 31 December 2015 in document A69/45. Voluntary contributions receivable – non-current are amounts that according to the donor agreement are due to be received more than one year after the balance sheet date being reported. Voluntary contributions receivable – current are amounts that according to the payment terms given in the agreement with the contributor are due as at or within one year of the balance sheet date, or where no payment terms are specified in the agreement. Amounts are aged from the due date of the invoice to the balance sheet date and hence amounts showing with ageing more than 360 days are overdue.
26
Annex
A69/INF./3
World Health Organization Schedule 5 – In-kind and in-service voluntary contributions For the year ended 31 December 2015 (in US dollars) Contributor Member States Azerbaijan Belgium Botswana Canada Democratic Republic of the Congo Denmark Gabon Germany India Iran (Islamic Republic of) Italy Japan Lebanon Lesotho Malaysia Maldives Morocco Namibia Oman Philippines Republic of Korea Saudi Arabia Senegal Singapore Sudan Syrian Arab Republic Thailand United Kingdom of Great Britain and Northern Ireland United States of America Uzbekistan Yemen Total Member States 120 000 144 000 30 613 972 9 872 040 100 000 120 000 351 167 273 326 7 576 565 140 000 216 000 365 463 60 000 96 000 250 000 10 993 685 120 000 4 138 204 3 700 000 148 251 100 000 132 000 90 000 7 767 000 140 000 101 312 1 178 807 180 000 100 000 317 760 120 000 40 953 77 707 353 079 50 000 752 507 72 226 60 000 168 226 250 000 11 746 192 120 000 4 188 204 3 700 000 148 251 100 000 132 000 90 000 7 767 000 140 000 101 312 1 531 886 180 000 100 000 317 760 120 000 40 953 77 707 140 000 216 000 365 463 100 000 120 000 351 167 273 326 7 576 565 120 000 144 000 40 486 012 In-kind In-service Total
American Leprosy Missions (ALM) Bayer AG Cisco Systems, Inc. Communauté Urbaine de Lyon, France Eisai Co., Ltd 1 340 452 246 901 83 673 10 199 320
81 281
81 281 1 340 452 246 901 83 673 10 199 320
27
A69/INF./3
Annex
Contributor Fondation des Immeubles pour les Organisations Internationales (FIPOI) Generalitat de Catalunya, Spain Gilead Sciences Inc. GlaxoSmithKline (GSK) Gojo Industries Inc. Government of Guam Impact EMR International Coordinating Group on Vaccine Provision for Epidemic Meningitis International Health Partners (IHP) International Medical Corps Johnson and Johnson Family of Companies Contribution Fund, Inc. Kobe Group (Hyogo Prefecture Kobe Chamber of Commerce and Industry and Kobe Steel, Ltd.) Kosovo La Métropole Grand Lyon Merck National Cancer Center, Korea Novartis Qiagen Sanofi Espoir Save the Children The Norwegian Refugee Council (NRC) Toyota Motor Corporation United Nations Development Programme (UNDP) Wellcome Trust World Organization for Animal Health (OIE) Total in-kind and in-service contributions (Note)
In-kind 146 923 172 454 537 875 22 656 948 107 464 431 404
In-service
Total 146 923 172 454 537 875 22 656 948 107 464 431 404
332 674 3 769 880 1 886 480 273 500 9 769 219 1 284 625 50 000 172 240 15 832 295 185 830 9 170 188 250 000 964 229 55 000 65 625 457 100 8 337 099 242 843 323 500 110 143 642 19 769 392
332 674 3 769 880 1 886 480 273 500 9 769 219 1 284 625 50 000 172 240 15 832 295 185 830 9 170 188 250 000 964 229 55 000 65 625 457 100 8 337 099 242 843 323 500 129 913 034
Note: Contributions in-kind and in-service are recorded by WHO at an amount equal to their estimated fair market value. An entry corresponding to the expense is recorded in the same period that the contributions in-kind and in-service are recorded as revenue. The total in-kind and in-service voluntary contributions are reported in the Statement of Financial Performance and summarized in Note 5.1 to the Financial Statements for the year ended 31 December 2015 in document A69/45.
28
Annex
A69/INF./3
World Health Organization Schedule 6 – Voluntary contributions received in advance for 2016 As at 31 December 2015 (in US dollars) Contributor Member States France Lao People’s Democratic Republic Republic of Korea Swaziland Thailand Turkey Total Member States 1 466 319 134 636 2 121 900 46 079 17 162 60 000 3 846 097 Total
Bill & Melinda Gates Foundation Médecins Sans Frontières (MSF) Merck
1 510 440 100 250 130 000
Total voluntary contributions received in advance (Note)
5 586 787
Note: Voluntary contributions received in advance are reported in the Statement of Financial Position and detailed as part of Note 4.9 to the Financial Statements for the year ended 31 December 2015 in document A69/45. Advances are recorded when contributions are received in advance of the start date of the activity as indicated in the agreements with contributors.
=
=
=
29